This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jerry H. Gurwitz, MD; Nananda F. Col, MD, MPP; Jerry Avorn, MD

JAMA. 1992;268(11):1417-1422.

Abstract
Objective.
—To determine the extent to which the elderly have been excluded from trials of drug therapies used in the treatment of acute myocardial infarction, to identify factors associated with such exclusions, and to explore the relationship between the exclusion of elderly and the representation of women.

Data Sources.
—We conducted a systematic search of the English-language literature from January 1960 through September 1991 to identify all relevant studies of specific pharmacotherapies employed in the treatment of acute myocardial infarction. To accomplish this, we searched MEDLINE, major cardiology textbooks, meta-analyses, reviews, editorials, and the bibliographies of all identified articles.

Study Selection.
—Only trials in which patients were randomly allocated to receive a specific therapeutic regimen or a placebo or nonplacebo control regimen were included for review.

Data Extraction.
—Studies were abstracted for year of publication, source of support, performance location, drug therapies to which patients were randomized, use of invasive diagnostic tests or therapeutic procedures, exclusion criteria, size and demographic characteristics of the randomized study population, and principal outcome measures.

Data Synthesis.
—A total of 214 trials met inclusion criteria, involving 150920 study subjects. Over 60% of trials excluded persons over the age of 75 years. Studies published after 1980 were more likely to have age-based exclusions compared with studies published before 1980 (adjusted odds ratio, 4.92; 95% confidence interval, 2.33 to 10.54). Trials of thrombolytic therapy involving an invasive procedure were more likely to exclude elderly patients compared with other studies (adjusted odds ratio, 2.45; 95% confidence interval, 1.10 to 5.47). Studies with age-based exclusions had a smaller percentage of women compared with those without such exclusions (18% vs 23%; P=.0002), with the mean age of the study population significantly associated with the proportion of women participants (P=.0001, R²=.29).

Conclusions.
—Age-based exclusions are frequently used in clinical trials of medications used in the treatment of acute myocardial infarction. Such exclusions limit the ability to generalize study findings to the patient population that experiences the most morbidity and mortality from acute myocardial infarction.

(JAMA. 1992;268:1417-1422)

Author Affiliations
From the Program for the Analysis of Clinical Strategies, Gerontology Division, Brigham and Women's Hospital, and the Harvard Research and Training Center (Drs Gurwitz and Avorn); the Hebrew Rehabilitation Center for Aged (Dr Gurwitz), Boston, Mass; and the Department of Family and Community Medicine, University of Massachusetts Medical School, Worcester, Mass (Dr Col).

Footnotes
Reprint requests to Program for the Analysis of Clinical Strategies, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115 (Dr Gurwitz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
Huynh et al.
Circulation 2009;119:3101-3109.
ABSTRACT | FULL TEXT  

Status of Women in Cardiovascular Clinical Trials
Kim and Menon
Arterioscler. Thromb. Vasc. Bio. 2009;29:279-283.
FULL TEXT  

Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
Lim et al.
J Am Coll Cardiol Intv 2009;2:146-152.
ABSTRACT | FULL TEXT  

The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research
Go et al.
Circ Cardiovasc Qual Outcomes 2008;1:138-147.
ABSTRACT | FULL TEXT  

Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies
Nallamothu et al.
Circulation 2008;118:1294-1303.
FULL TEXT  

Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure
Piccini et al.
Circulation 2008;118:926-933.
ABSTRACT | FULL TEXT  

Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia
Rochon et al.
Arch Intern Med 2008;168:1090-1096.
ABSTRACT | FULL TEXT  

Variations Between Clinical Trial Participants and Medicare Beneficiaries in Evidence Used for Medicare National Coverage Decisions
Dhruva and Redberg
Arch Intern Med 2008;168:136-140.
ABSTRACT | FULL TEXT  

Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self-Reporting Systems
Glasser et al.
J Clin Pharmacol 2007;47:1074-1086.
ABSTRACT | FULL TEXT  

Population Issues in Clinical Trials
Mosenifar
Proc Am Thorac Soc 2007;4:185-188.
ABSTRACT | FULL TEXT  

Regional Differences in Process of Care and Outcomes for Older Acute Myocardial Infarction Patients in the United States and Ontario, Canada
Ko et al.
Circulation 2007;115:196-203.
ABSTRACT | FULL TEXT  

Underinvestigation and undertreatment of carotid disease in elderly patients with transient ischaemic attack and stroke: comparative population based study
Fairhead and Rothwell
BMJ 2006;333:525-527.
ABSTRACT | FULL TEXT  

Evaluating Drug Effects in the Post-Vioxx World: There Must Be a Better Way
Avorn
Circulation 2006;113:2173-2176.
FULL TEXT  

Potential Consequences for Recruitment, Power, and External Validity of Requirements for Additional Risk Factors for Eligibility in Randomized Controlled Trials in Secondary Prevention of Stroke
Howard et al.
Stroke 2006;37:209-215.
ABSTRACT | FULL TEXT  

Reader's guide to critical appraisal of cohort studies: 1. Role and design
Rochon et al.
BMJ 2005;330:895-897.
FULL TEXT  

Exercise Single-Photon Emission Computed Tomography Provides Effective Risk Stratification of Elderly Men and Elderly Women
Valeti et al.
Circulation 2005;111:1771-1776.
ABSTRACT | FULL TEXT  

Randomized Controlled Drug Trials on Very Elderly Subjects: Descriptive and Methodological Analysis of Trials Published Between 1990 and 2002 and Comparison With Trials on Adults
Le Quintrec et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:340-344.
ABSTRACT | FULL TEXT  

Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and risks
Mehta et al.
J Am Coll Cardiol 2005;45:471-478.
ABSTRACT | FULL TEXT  

Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?
Gurwitz
Arch Intern Med 2004;164:1957-1959.
FULL TEXT  

Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction: Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
Guagliumi et al.
Circulation 2004;110:1598-1604.
ABSTRACT | FULL TEXT  

A Single Mathematical Model Predicts Physicians' Recommendations and Postmenopausal Women's Decisions to Participate in a Clinical Trial to Prevent Breast Cancer or Coronary Heart Disease
Veit
Med Decis Making 2004;24:330-350.
ABSTRACT  

Use of Angiotensin-Converting Enzyme Inhibitors in Elderly People With Heart Failure: Prevalence and Outcomes
Pedone et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M716-M721.
ABSTRACT | FULL TEXT  

The Quality of Pharmacologic Care for Vulnerable Older Patients
Higashi et al.
ANN INTERN MED 2004;140:714-720.
ABSTRACT | FULL TEXT  

Gender differences in advanced heart failure: insights from the BEST study
Ghali et al.
J Am Coll Cardiol 2003;42:2128-2134.
ABSTRACT | FULL TEXT  

Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot et al.
JAMA 2003;290:898-904.
ABSTRACT | FULL TEXT  

Patient-Centered Cardiac Care for the Elderly: TIME for Reflection
Peterson
JAMA 2003;289:1157-1158.
FULL TEXT  

Effect of long-term therapy with ramipril in high-risk women
Lonn et al.
J Am Coll Cardiol 2002;40:693-702.
ABSTRACT | FULL TEXT  

Principles From Clinical Trials Relevant to Clinical Practice: Part I
Califf and DeMets
Circulation 2002;106:1015-1021.
FULL TEXT  

Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat et al.
Arch Intern Med 2002;162:1682-1688.
ABSTRACT | FULL TEXT  

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)
Hasdai et al.
Eur Heart J 2002;23:1190-1201.
ABSTRACT | FULL TEXT  

Acute myocardial infarction in the elderly: differences by age
Mehta et al.
J Am Coll Cardiol 2001;38:736-741.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease
SIN and TU
Am. J. Respir. Crit. Care Med. 2001;164:580-584.
ABSTRACT | FULL TEXT  

Representation of Elderly Persons and Women in Published Randomized Trials of Acute Coronary Syndromes
Lee et al.
JAMA 2001;286:708-713.
ABSTRACT | FULL TEXT  

Dementia and Disability Outcomes in Large Hypertension Trials: Lessons Learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial
Di Bari et al.
Am J Epidemiol 2001;153:72-78.
ABSTRACT | FULL TEXT  

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction : Results From the Cooperative Cardiovascular Project
Brass et al.
Stroke 2000;31:1802-1811.
ABSTRACT | FULL TEXT  

Ageism in cardiology
Bowling
BMJ 1999;319:1353-1355.
FULL TEXT  

Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996
Tu et al.
CMAJ 1999;161:1257-1261.
ABSTRACT | FULL TEXT  

Methods in health services research: Interpreting the evidence: choosing between randomised and non-randomised studies
McKee et al.
BMJ 1999;319:312-315.
FULL TEXT  

Pursuing Reform in Clinical Research: Lessons from Women's Experience
Eckenwiler
J Law Med Ethics 1999;27:158-170.
 

Prevalence, Clinical Correlates, and Treatment of Hypertension in Elderly Nursing Home Residents
Gambassi et al.
Arch Intern Med 1998;158:2377-2385.
ABSTRACT | FULL TEXT  

Age related outcome in acute myocardial infarction
McMechan and Adgey
BMJ 1998;317:1334-1335.
FULL TEXT  

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) trial
Lewis et al.
J Am Coll Cardiol 1998;32:140-146.
ABSTRACT | FULL TEXT  

Gender trends in sick-listing with musculoskeletal symptoms in a Swedish county during a period of rapid increase in sickness absence
Leijon et al.
Scand J Public Health 1998;26:204-213.
ABSTRACT  

Rating the Appropriateness of Coronary Angiography -- Do Practicing Physicians Agree with an Expert Panel and with Each Other?
Ayanian et al.
NEJM 1998;338:1896-1904.
ABSTRACT | FULL TEXT  

Meta-analysis Spurious precision? Meta-analysis of observational studies
Egger et al.
BMJ 1998;316:140-144.
FULL TEXT  

Medicine based evidence, a prerequisite for evidence based
and
BMJ 1997;315:1109-1110.
FULL TEXT  

Exclusion of Elderly Subjects From Clinical Trials for Parkinson Disease
Mitchell et al.
Arch Neurol 1997;54:1393-1398.
ABSTRACT  

Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association
Mosca et al.
Circulation 1997;96:2468-2482.
FULL TEXT  

Improved Outcome of Elderly Patients (>=75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel
Gottlieb et al.
Circulation 1997;95:342-350.
ABSTRACT | FULL TEXT  

Variability in Length of Hospitalization for Stroke: The Role of Managed Care in an Elderly Population
Monane et al.
Arch Neurol 1996;53:875-880.
ABSTRACT  

Influence of Race, Sex, and Age on Management of Unstable Angina and Non--Q-Wave Myocardial Infarction: The TIMI III Registry
Stone et al.
JAMA 1996;275:1104-1112.
ABSTRACT  

Gender Influences the Magnitude of the Inflammatory Response Within Embolic Cerebral Infarcts in Young Rats
Li et al.
Stroke 1996;27:498-503.
ABSTRACT | FULL TEXT  

The Impact of Clinical Trials on the Use of Medications for Acute Myocardial Infarction: Results of a Community-Based Study
Col et al.
Arch Intern Med 1996;156:54-60.
ABSTRACT  

Sex Differences in Perioperative and Long-term Cardiac Event–Free Survival in Vascular Surgery Patients : An Analysis of Clinical and Scintigraphic Variables
Hendel et al.
Circulation 1995;91:1044-1051.
ABSTRACT | FULL TEXT  

The Exclusion of Women from Clinical Trials of Thrombolytic Therapy: Implications for Developing the Thrombolytic Predictive Instrument Database
Maynard et al.
Med Decis Making 1995;15:38-43.
ABSTRACT  

Recent Trends in Hospital Mortality of Acute Myocardial Infarction--the Worcester Heart Attack Study: Have Improvements Been Realized for All Age Groups?
Gurwitz et al.
Arch Intern Med 1994;154:2202-2208.
ABSTRACT  

Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables
McClellan et al.
JAMA 1994;272:859-866.
ABSTRACT  

Grassroots AIDS Knowledge: Implications for the Boundaries of Science and Collective Action
Indyk and Rier
Science Communication 1993;15:3-43.
ABSTRACT  

Cardiovascular Health and Disease in Women
Wenger et al.
NEJM 1993;329:247-256.
FULL TEXT  

Technology Follies: The Uncritical Acceptance of Medical Innovation
Grimes
JAMA 1993;269:3030-3033.
ABSTRACT  

EXCLUSION OF THE ELDERLY FROM POST-MI DRUG RESEARCH
JWatch General 1992;1992:7-7.
FULL TEXT  

Exclusion of the Elderly and Women From Coronary Trials: Is Their Quality of Care Compromised?
Wenger
JAMA 1992;268:1460-1461.
ABSTRACT  

Metoprolol CR/XL in Female Patients With Heart Failure: Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
Ghali et al.
Circulation 2002;105:1585-1591.
ABSTRACT | FULL TEXT